Open AccessNephrotic Syndrome Induced by Lenvatinib Treatment for Hepatocellular Carcinoma
Author(s) -
Thaninee Prasoppokakorn,
Kessarin Thanapirom,
Sombat Treeprasertsuk
Publication year - 2022
Publication title -
case reports in hepatology
Language(s) - Uncategorized
Resource type - Journals
eISSN - 2090-6595
pISSN - 2090-6587
DOI - 10.1155/2022/5101856
Subject(s) - lenvatinib , medicine , hepatocellular carcinoma , hypoalbuminemia , gastroenterology , sorafenib , discontinuation , nephrotic syndrome , proteinuria , adverse effect , oncology , kidney
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom